Primary early-onset glaucoma

Primary early-onset glaucoma is a group of rare eye disorders characterized by elevated intraocular pressure (IOP) that develops during infancy, childhood, or young adulthood, leading to progressive damage to the optic nerve and potential vision loss. This category encompasses several subtypes, including primary congenital glaucoma (presenting at birth or within the first few years of life) and juvenile open-angle glaucoma (typically presenting between ages 3 and 40). The condition primarily affects the eye's aqueous humor drainage system, specifically the trabecular meshwork and anterior chamber angle structures, resulting in impaired outflow of fluid and consequent elevation of intraocular pressure. Key clinical features include elevated intraocular pressure, optic nerve cupping, and progressive visual field loss. In congenital forms, characteristic signs include buphthalmos (enlargement of the eye), corneal edema, excessive tearing (epiphora), photophobia, and Haab striae (breaks in Descemet's membrane). Juvenile forms may present more subtly, with elevated IOP and optic disc changes detected during routine examination. Several genes have been implicated, including CYP1B1 (associated with autosomal recessive primary congenital glaucoma), MYOC (associated with autosomal dominant juvenile open-angle glaucoma), LTBP2, and TEK, among others. Treatment focuses on lowering intraocular pressure to prevent further optic nerve damage and preserve vision. Surgical intervention is typically the first-line treatment for congenital glaucoma, with procedures such as goniotomy or trabeculotomy being most commonly performed. Trabeculectomy and glaucoma drainage devices may be considered in refractory cases. For juvenile open-angle glaucoma, medical therapy with topical IOP-lowering agents (such as prostaglandin analogs, beta-blockers, or carbonic anhydrase inhibitors) may be attempted initially, with surgery reserved for cases unresponsive to medication. Early diagnosis and treatment are critical to preserving vision, and lifelong monitoring is required as the condition is chronic and progressive.

Common questions about Primary early-onset glaucoma